Single-photon Emission Computed Tomography Market To Reach $4.54 Billion By 2030

Single-photon Emission Computed Tomography Market Growth & Trends

The global single-photon emission computed tomography market size is expected to reach USD 4.54 billion by 2030, registering a CAGR of 2.78% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors. One of the primary market drivers is the increasing prevalence of cancer. The increasing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions is a significant driver of the single-photon emission computed tomography (SPECT) market.

As the population ages, the incidence of these diseases rises, creating a greater demand for accurate diagnostic tools such as SPECT imaging. This trend necessitates the adoption of advanced imaging technologies that can provide detailed insights into disease progression and treatment efficacy, thereby boosting the SPECT market in the region.

Government support through funding for healthcare facilities and initiatives to improve access to advanced imaging technologies is further propelling market growth. In addition, the integration of SPECT with other imaging modalities, such as CT (SPECT/CT), enhances diagnostic accuracy and expands its applications in various medical fields.Manufacturers and healthcare providers are actively collaborating to advance SPECT technology and expand its use in clinical practice.

Major players in the market, such as Cardinal Health, GE Healthcare, and Siemens Healthineers, are investing in research and development to innovate and optimize SPECT systems. These companies are also forming partnerships with hospitals and research institutions to facilitate clinical trials and the introduction of new radiopharmaceuticals, which are essential for SPECT imaging. The collaboration between manufacturers and healthcare facilities ensures that the latest technologies are readily available to clinicians, thereby improving patient outcomes.

The launch of new products and the integration of cutting-edge technologies are key trends in the SPECT market. Recent advancements include the development of high-resolution imaging systems and novel radiopharmaceuticals that enhance the sensitivity and specificity of SPECT scans. For instance, the introduction of a cutting-edge scanner is expected to transform nuclear medicine services at QEII Health Sciences Centre by providing clinicians with enhanced tools for better diagnosis and treatment planning. This aligns with the center's commitment to delivering high-quality healthcare through the adoption of innovative technologies. Such scanner's installation represents a significant investment in healthcare infrastructure, aimed at improving patient outcomes.

Further, the introduction of hybrid imaging systems such as SPECT/CT in hospital settings has revolutionized the field by providing comprehensive anatomical and functional imaging, which is crucial for accurate diagnosis and treatment planning. For instance, in May 2024, Mercy Sullivan Hospital installed a high-tech SPECT/CT imaging system, enhancing its diagnostic capabilities. The new system, which integrates advanced SPECT and CT technologies, was designed to provide detailed and accurate imaging for a variety of medical conditions.

The installation marked a significant upgrade for the hospital, improving its ability to diagnose and monitor diseases more effectively. The new SPECT/CT system aims to support better patient care by offering higher resolution images and more precise diagnostic information.These innovations not only improve diagnostic capabilities but also foster greater interdisciplinary collaboration among healthcare professionals, leading to more effective patient management strategies.

Some of the key players in the market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Spectrum Dynamics Medical, Digirad Corporation, MILabs B.V., Mediso Medical Imaging Systems, MiE GmbH. Key player are involved in undertaking strategic initiatives such as product launch to cater global clientele. In October 2022, Spectrum Dynamics announced its advancement in digital nuclear medicine imaging with the launch of the VERITON-CT-400 Series Digital SPECT/CT scanners. These new scanners utilize solid-state detector technology and feature a wide-bore configuration, enabling them to image high-energy isotopes with enhanced precision and capability.

 Request a free sample copy or view report summary: Single-photon Emission Computed Tomography Market Report

Single-photon Emission Computed Tomography Market Report Highlights

• Based on product, hybrid SPECT systems accounted for largest revenue share of 67.12% in 2023. These hybrid systems integrate SPECT's functional imaging capabilities with the anatomical detail provided by CT or MRI, offering a comprehensive view that enhances diagnostic accuracy and treatment planning. Hybrid SPECT systems are used in various medical applications, including oncology, cardiology, and neurology, to provide detailed insights into the physiological and anatomical aspects of the body

• Based on application, oncology dominated the market and accounted for the largest share of 49.58% in 2023. The rising global incidence of cancer is driving the growth of the nuclear imaging market, particularly in PET and SPECT technologies. These advanced modalities have gained widespread adoption due to their unparalleled ability to visualize the molecular characteristics of cancer, providing a deeper understanding of the disease

• Based on end use, hospitals segment is dominated the end use segments with the largest market share of 46.9% in 2023. This is attributable to advanced imaging technologies in hospitals that enable the early detection of cancer, CVD’s, allowing for prompt intervention and treatment. In addition, partnerships & collaborations between hospitals and other companies to meet clinical needs contribute to market growth

• North America dominated the global market due to the attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, the high prevalence of cancer and chronic diseases, and rapid adoption of innovative technologies

• Asia Pacific region is expected to witness fastest growth with a CAGR of 3.51% over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities 

Single-photon Emission Computed Tomography Market Segmentation

Grand View Research has segmented single-photon emission computed tomography (SPECT) market based on product, application, end use, and region: 

Single-photon Emission Computed Tomography (SPECT) Product Outlook (Revenue, USD Million, 2018 - 2030)

• Stand-alone SPECT Systems

• Hybrid SPECT Systems

Single-Photon Emission Computed Tomography (SPECT) Application Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiology

• Oncology

• Neurology

• Other Applications

Single-Photon Emission Computed Tomography (SPECT) End Use Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Diagnostics Imaging Centers

• Research & Development Institutes

• Others End Users

Single-Photon Emission Computed Tomography (SPECT) Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Mexico

• Europe

• UK

• Germany

• France

• Italy 

• Spain

• Denmark

• Sweden

• Norway

• Asia Pacific

• Japan

• China

• India

• Australia

• Thailand

• South Korea

• Latin America

• Brazil

• Argentina

• Middle East Africa

• South Africa

• Saudi Arabia

• UAE

• Kuwait

List of Key Players in the Single-photon Emission Computed Tomography (SPECT) Market

• GE Healthcare

• Siemens Healthineers

• Koninklijke Philips N.V.

• Spectrum Dynamics Medical

• Digirad Corporation

• MILabs B.V.

• Mediso Medical Imaging Systems

• MiE GmbH